2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes

Manufacturer Identification, Visual Cues, and Color Codes

Core Verification Rule: Visual inspection is the final defensive physical barrier against wrong-drug, wrong-strength, and cross-contamination dispensing errors. A verifying technician must examine the physical dosage form—confirming its imprint code, color, shape, size, scoring, and container cap color—against certified compendial standards before releasing the product.

While automated barcode verification catches barcode-to-label mismatches, only human or visual technical product verification (TPV) detects physical tablet mismatches, rogue pills from previous dispensing cycles, damaged dosage forms, and incorrect liquid cap colors.

---

1. Warfarin Sodium Tablet Color Standardization

Because warfarin sodium (Coumadin, Jantoven) is a high-alert Narrow Therapeutic Index (NTI) oral anticoagulant with extreme risk of life-threatening hemorrhage or thromboembolism, the pharmaceutical industry and the FDA established a nationally standardized color-coding system. Every commercial manufacturer of warfarin in the United States—both brand and generic—must formulate each tablet strength in the identical standardized color.

The Standardized Warfarin Color Matrix

The Universal Clinical Mnemonic

To ensure rapid recall during verification, memorizing the first letters in ascending strength order is standard practice:

"Please Let Greg Tell Boys Peach Teal Yellow White"

  P  - Pink       = 1 mg
  L  - Lavender   = 2 mg
  G  - Green      = 2.5 mg
  T  - Tan        = 3 mg
  B  - Blue       = 4 mg
  P  - Peach      = 5 mg
  T  - Teal       = 6 mg
  Y  - Yellow     = 7.5 mg
  W  - White      = 10 mg

[!IMPORTANT] Why Warfarin Color Matching is Life-or-Death: Anticoagulation clinics and patients routinely adjust warfarin dosages by tablet color (e.g., 'Take one peach tablet on weekdays and half a blue tablet on weekends'). If a verifying technician fails to notice that 5 mg peach tablets were dispensed instead of 2.5 mg green tablets, the patient will receive a 100% warfarin overdose, leading to severe internal hemorrhage, hematuria, or fatal hemorrhagic stroke.

---

2. Levothyroxine Sodium Tablet Color Standards

Levothyroxine sodium (Synthroid, Levoxyl, Unithroid) is dosed in micrograms (mcg). Because a minute 25 mcg dosing error can induce cardiac arrhythmias, osteoporosis, or severe hypothyroidism, major manufacturers follow a consistent color scheme across 12 commercial tablet strengths.

[!WARNING] Microgram vs. Milligram Metric Traps: Technicians must be vigilant when verifying levothyroxine orders written in milligrams vs. micrograms:

• 0.025 mg = 25 mcg (Orange)
• 0.05 mg = 50 mcg (White)
• 0.1 mg = 100 mcg (Yellow)
• 0.2 mg = 200 mcg (Pink)

Confusing 0.025 mg with 0.25 mg (which does not exist, but could be misread as 200 mcg or 300 mcg) results in massive over- or under-dosing.

---

3. Ophthalmic Bottle Cap Color Coding (AAO Standards)

The American Academy of Ophthalmology (AAO) established an industry-wide cap color standard for topical ophthalmic medications. Because ophthalmic patients frequently suffer from impaired vision, cataracts, or severe glaucoma, cap colors serve as a critical visual safety mechanism.

Ophthalmic Verification Check: Route MUST BE 'FOR THE EYE ONLY' (Ophthalmic)
NEVER dispense Otic (ear) drops for Ophthalmic use (Otic drops are non-sterile and acidic!)

---

4. Solid Oral Dosage Form Physical Markings & Imprint Mandate

FDA Imprint Code Regulation (21 CFR Part 206)

Under federal law (21 CFR § 206.10), no commercial solid oral drug product (prescription or over-the-counter tablet, capsule, or caplet) may be introduced into interstate commerce unless it bears a clearly readable, unique debossed, embossed, or printed imprint code.

The Elements of the Imprint Code

An imprint code consists of any single letter, number, word, mark, symbol, or logo—or any combination thereof—that, when combined with the product's size, shape, and color, enables unequivocal identification of the active drug moiety, strength, and manufacturer/distributor.

• Debossed Imprint: Imprinted into the tablet surface during compression using engraved punches.
• Embossed Imprint: Raised above the surface of the tablet.
• Printed Imprint: Applied using food-grade pharmaceutical ink onto film-coated tablets or hard/soft gelatin capsule shells.

Exemptions Under 21 CFR § 206.7

21 CFR § 206.7 — not § 206.10 — is where the exemptions live, and it names categories, never individual drug products.

Categorically exempt (no application needed):

1. Drug products intended for use in a clinical investigation under section 505(i) of the Act, other than treatment INDs.
2. Drugs, other than reference listed drugs, intended for use in bioequivalence studies.
3. Drugs extemporaneously compounded by a licensed pharmacist for an individual patient.
4. Radiopharmaceutical drug products.

Exempt only on a granted request:

• Products whose size, shape, texture, or other physical characteristics make imprinting technologically infeasible or impossible — the applicant must request the exemption in writing from the appropriate CDER or CBER review division.
• Products administered solely in controlled health care settings and not provided to patients for self-administration — also by written request.

[!CAUTION] Do not repeat the sublingual-nitroglycerin myth. A very common claim in technician study material is that sublingual nitroglycerin is exempt from imprinting because it is too small and too volatile. It is not exempt, and it is not unimprinted. Per the current Nitrostat labeling, the tablets are white, round, flat-faced, and coded "N" on one side with the strength digit on the other: N / 3 for 0.3 mg, N / 4 for 0.4 mg, and N / 6 for 0.6 mg. When a physical dosage form is genuinely unimprinted, the realistic explanations are that it is a compounded preparation, an investigational product, or a radiopharmaceutical — not that "small tablets are exempt."

---

5. Visual Inspection Protocol & Database Verification

During technical product verification, verifying technicians must execute a structured 5-point physical inspection:

1. Imprint Verification: Read the exact characters on both sides of the solid dosage form (e.g., 'M / 30', 'IP 109', 'TV / 58', 'WATSON / 853'). Look up the imprint code in a certified compendial database:
   • DailyMed (National Library of Medicine / official FDA package labels)
   • Lexicomp / Micromedex / Facts & Comparisons / Ident-A-Drug
2. Shape & Contour Check: Verify whether the dosage form is round, oval, oblong/capsule-shaped, triangular, square, biconvex, or flat-faced.
3. Color & Coating Check: Inspect for accurate shade (e.g., lavender vs pink), coating type (film-coated vs enteric-coated vs sugar-coated), and uniformity (no mottling, speckling, or discoloration).
4. Scoring Verification: Check whether the tablet is unscored, single-scored (bisected), or quadrisected. If a prescription specifies taking half-tablets, the dispensed tablet must be FDA-approved as scoreable.
5. Dosage Form Integrity & Debris Check: Inspect the counting tray or unit-dose packaging for chipped tablets, capped tablets (top splitting off), excessive powder/friability, moisture degradation, or foreign 'rogue' tablets accidentally dropped from an earlier prescription fill.